Open-angle glaucoma (OAG)
Clinical trials for Open-angle glaucoma (OAG) explained in plain language.
Never miss a new study
Get alerted when new Open-angle glaucoma (OAG) trials appear
Sign up with your email to follow new studies for Open-angle glaucoma (OAG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma
Disease control OngoingThis early study tests whether QLS-111 eye drops can improve blood flow to the back of the eye in people with non-proliferative diabetic retinopathy or certain types of glaucoma. Fourteen participants will use the drops twice daily for two weeks. The main goal is to measure chang…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase 2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a tiny eye implant replace daily drops for glaucoma?
Disease control OngoingThis early-stage trial is testing a single biodegradable implant placed in the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. The implant slowly releases medication over time and then dissolves. The study includes 12 adults and focuses on safety,…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase 1 • Sponsor: PolyActiva Pty Ltd • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Glaucoma surgery checked 5 years later: does it hold up?
Knowledge-focused By invitation onlyThis study follows 250 people with open-angle glaucoma who had a new type of surgery called CycloPen, which aims to improve fluid drainage from the eye. Researchers will measure eye pressure at 3, 4, and 5 years after surgery to see if the benefits last. The goal is to understand…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Sponsor: Iantrek, Inc. • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC